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Blood stream infection (BSI) is one of the most devastating
preventable complications in Critical Care Units. It has
far-reaching consequences resulting in prolonged length of
hospital-stay, high costs to the individual and exchequer, and,
in many instances, loss of life. Although exact rates of BSI
differ markedly worldwide, figures in the US are around 19.8
episodes per 1000 central-line days (CI 95%; 16.1–23.6) with
an approximate incidence of 100,000 episodes annually [1];
the rate, in USA, falls to 5.8 (CI 95%; 3.8–7.8) when only
microbiologically documented episodes are considered [2]
and to 8.75% in Indian ICUs [3]. The need to bring these two
data groups (microbiologically proven and clinical sepsis) as
close as possible is every infectious disease specialist’s dream.
Advances in medical science have resulted in increased
interventions in critically ill patients creating foci fromwhere
bacteria can gain access to the blood stream resulting in
an increase nosocomial BSI. They represent about 15% of
all nosocomial infections and affect approximately 1% of all
hospitalized patients [1]. A hospital-related BSI would deem
to have occurred after a patient has completed ≥48 h of stay
in the hospital or has a central line for 48 h or more [4].
Community acquired BSIs can also occur. A BSI is primary
when the central line is the only probable source of infection
and secondary when there is an underlying cause for the
BSI (genitourinary/respiratory infection or any other obvious
source of infection in the body).
Among the bacterial causes of BSI, Staphylococcus
aureus, coagulase negative Staphylococci, and Enterococcus
faecalis are the commonest among Gram positive organisms;
Escherichia coli,Klebsiella pneumonia, and Serratia spp are the
commonest among Enterobacteriaceae; and Pseudomonas
spp andAcinetobacter baumannii are the commonest amongst
the nonfermenter Gram negative organisms [2, 5]. Among
fungi, it is nonalbicans Candida spp followed by Candida
albicans that are common [6]. However, organisms vary with
several factors such as (i) type of health-care facility involved,
(ii) presence of a central venous/arterial catheter, (iii) type of
catheter used, (iv) duration of catheterization, (v) prevalent
organisms in the center, (vi) immune status of the host,
(vii) underlying comorbidities, (viii) level of preventive and
barrier precautions undertaken, and (ix) initial antimicrobial
therapy [1, 7].
The severely immune-compromised patient is prone to
fungal as well as bacterial blood stream infections. However,
the lack of diagnostic tools for early detection of candidemia
and other fungal infections limits the number of studies on
this issue. Clinical and radiological signs are nonspecific,
and traditional culture-based tools suffer from low sensitivity.
Tests that have generated interest include combined detection
of mannan and anti-mannan antibodies, 𝛽-1, 3, D-glucan
detection, and a number of molecular techniques. Unfortu-
nately drawbacks of nonculture techniques include moderate
level of sensitivity and specificity and lack of standardization
[8].
Currently, multidrug resistant bacteria, residing in eco-
logical niches in hospitals, present therapeutic challenges
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when theymanifest as bacteremias [7]. Bacteriological profile
and drug resistance patterns tend to be peculiar to an institute
that is dealing with a special category of patients. In this issue,
a tertiary care center in Brazil reports a retrospective cohort
study of the prevalence of vancomycin resistant Enterococcus
faecium from BSI, and K. Gohel et al. report the profile
and drug resistance patterns of blood culture isolates from
a tertiary nephrourology institute of India. In India, the
burden of bacterial infection is estimated to be very high;
however, systematic data is limited [2]. Identification of the
extent of the problem generates evidence for advocacy for
regulation of currently unregulated antibiotics. Additionally,
such data guides the policy on implementation of antibiotic
stewardship programs and standardized infection control
guidelines. Knowledge of the pattern of antibiotic resistance
prevalent in severe infections could also motivate and direct
new drug discovery.
The need for early aggressive therapy in BSI cannot be
overemphasized. The “time-window” for administration of
appropriate therapy is <6 h once symptoms are apparent and
many agree that the very first hour is critical [9]. An ideal
platform must offer quick, specific diagnosis, be economical,
and have minimum hands-on time. Use of biomarkers for
diagnosis and monitoring of sepsis holds promise. Not only
do they distinguish infective from noninfective sepsis, but
also the serial use of biomarkers can be used for determining
effectiveness of an intervention. Procalcitonin and C-reactive
protein are already in use widely but the search is on for even
better agents. The performance of soluble triggering receptor
expressed on myeloid cells-I (sTREM-1), soluble urokinase-
type plasminogen receptor (suPAR), proadrenomedullin (pro
ADM), and presepsin appears promising and offers better
prognostic performance than procalcitonin [10, 11]. The
use of biomarkers in sepsis has been discussed in this
special issue. Apart from biomarkers, a mass-spectroscopy
based approach known as MALDI-TOF (Matrix-assisted
laser desorption/ionization time-of-flight mass spectrome-
try) can provide genus and species level identification within
minutes enabling significant time saving over conventional
methods of identification [12]. Research is on to determine
the potential of mass-spectrometry to provide other useful
information to the clinician, epidemiologists, and clinical
microbiologists, such as genotyping, virulence marker, and
resistance mechanism. A modified PCR/ESI-MS (PCR fol-
lowed by electrospray ionizationmass spectrometry)method
is now available and holds promise for detection of pathogen
directly from clinical samples.This evolvingmethod has been
discussed in this special issue. The need of the hour for the
technology sector is to work upon such tools that are not
only efficient but also economically viable so that developing
nations can benefit as, ironically, it is here that the need for
such measures is most.
The therapeutic challenges posed by the blood stream
pathogens make it imperative that better strategies are
developed to prevent infections. Education and training of
health-care workers, use of maximum sterile barrier precau-
tions for all patients on central/peripheral lines, and appro-
priate skin antisepsis during central venous catheter inser-
tions are some simple guidelines that can save precious
lives [12]. Medicated catheter-lock solutions and use of anti-
septic/antibiotic impregnated central venous catheter and
chlorhexidine impregnated sponge dressings are being look-
ed into in various centers [1, 4].
This special issue brings forth various aspects of blood
stream infections from around the world, including advances
in detection and use of possible alternative pharmaceutical
agents. The quest for reducing blood stream infections is
gaining momentum worldwide as in most cases, it is emi-
nently preventable. BSI that plagues critical care centers all
over the world is a continued challenge, has many formidable
frontiers, and remains an enigma even today. We hope this
issue will stimulate researchers to work on improving the
methodologies for detection, prevention, andmanagement of
blood stream infections so that we can reach a stage of “zero”
morbidity and mortality from this infection.
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